"City Nonprofit Partners with New York–Presbyterian and Mount Sinai on COVID Recovery Center" - Jonathan LaMantia

Novel Antibody Platform Tackles Viral Mutations

Mount Sinai Opens State-of-the-Art Center for Patients With Complex Conditions Including Lyme Disease and Long COVID

Whats the Risk of Getting Long COVID in 2024

Mount Sinai Expands Center For Post-COVID Care To Serve Patients In East Harlem And South Bronx

Mount Sinai Expands Center for Post-COVID Care to Serve Patients in East Harlem and South Bronx

SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phasening phase followed by a stabilization phase

Study finds long-lasting antibodies after COVID-19 vaccine

Long-Term Data Reveals SARS-CoV-2 Infection and Vaccine-Induced Antibody Responses Are Long-Lasting

Mount Sinai Receives $2.6 Million Grant From PolyBio Research Foundation for Long COVID Clinical Trials

Mount Sinai Is First in "New York" to Study a Brain-Computer Interface Designed to Record

CastleVax Inc. Receives BARDA Project NextGen Award Valued at up to $338 Million to Advance Intranasal NDV-based COVID-19 Booster Vaccine into Phase 2b Clinical Efficacy Testing